Risk Factors for the Relapse of Graves’ Disease Treated With Antithyroid Drugs: A Systematic Review and Meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk Factors for the Relapse of Graves’ Disease Treated With Antithyroid Drugs: A Systematic Review and Meta-analysis

Published:2020-04 Issue:4 Volume:42 Page:662-675.e4
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Shi He,Sheng Rongrong,Hu Yifang,Liu Xiaoyun,Jiang Lin,Wang Zhongmin,Cui Dai

Funder

Jiangsu Province

Priority Academic Program Development of Jiangsu Higher Education Institutions

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference65 articles.

1. Hyperthyroidism

2. Comparative efficacy of four treatments in patients with Graves' disease: a network meta-analysis;Ren;Exp Clin Endocrinol Diabetes,2015

3. Issues and epidemiological evidence regarding radiation-induced thyroid cancer;Shore;Radiat Res,1992

4. Antithyroid drugs;Cooper;N Engl J Med,2005

5. Can we predict relapse in Graves' disease? Results from a systematic review and meta-analysis;Struja;Eur J Endocrinol,2017

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Anti-Thyroid Medications in Patients with Graves’ Disease;BMC Endocrine Disorders;2024-09-06

2. Hyperthyroidism in Graves’ disease: practical advice on the choice of treatment and indications for radioiodine use;Polish Archives of Internal Medicine;2024-05-28

3. Quemeiteng granule relieves goiter by suppressing thyroid microvascular endothelial cell proliferation and angiogenesis via miR-217-5p-mediated targeting of FGF2-induced regulation of the ERK pathway;Journal of Ethnopharmacology;2024-05

4. Enhanced predictive validity of integrative models for refractory hyperthyroidism considering baseline and early therapy characteristics: a prospective cohort study;Journal of Translational Medicine;2024-03-29

5. Efficacy Of Methimazole Versus Radioiodine in Patients With Hyperthyroidism: A Meta-analysis Of Randomized Controlled Trials;2023-11-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3